HIV Protective KIR3DL1/S1-HLA-B Genotypes Influence NK Cell-Mediated Inhibition of HIV Replication in Autologous CD4 Targets

English version České info

Carriage of the genetic combination encoding a high expression inhibitory Killer Immunoglobulin-like Receptor (KIR)3DL1 with its ligand, HLA-B*57 (*h/*y+B*57) is associated with slower time to AIDS and better HIV viral load control than being a Bw6 homozygote (Bw6hmz). Natural Killer (NK) cells from *h/*y+B*57 carriers receive potent educational signals through HLA-B*57 KIR3DL1 ligation leading to high functional potential. NK cells from Bw6hmz are not educated through KIR3DL1 because Bw6 antigens do not interact with this inhibitory receptor. To better understand the impact of KIR/HLA combinations on NK cell mediated anti-viral activity we measured NK cell mediated inhibition of HIV replication in autologous infected CD4 (iCD4) cells by assessing the frequency of p24 positive CD4 targets and supernatant levels of HIV p24 longitudinally in the presence versus absence of NK cells. Forty-seven HIV uninfected subjects were studied, including carriers of *h/*y+B*57, a low expression KIR3DL1 genotype with HLA-B*57 termed *l/*x+B*57, a genotype designated 3DS1+*80I and Bw6hmz. NK cells from *h/*y+B*57 carriers, like those from 3DS1+*80I subjects, inhibited HIV replication in autologous iCD4 cells better than those from Bw6hmz and *l/*x+B*57 carriers. Cell contact between NK and iCD4 cells activated NK cells to inhibit viral replication in a non-contact dependent fashion through secretion of CC-chemokines. iCD4 stimulated NK cells from *h/*y+B*57 and 3DS1+*80I carriers produced higher levels of CC-chemokines than those from Bw6hmz or *l/*x+B*57 carriers. Higher levels of CC-chemokines were produced by KIR3DL1⁺ than KIR3DL1⁻ NK cells. We conclude that NK-mediated inhibition of viral replication in autologous iCD4 cells is partially due to a block at the level of HIV entry into new targets by secreted CC-chemokines.

Vyšlo v časopise: HIV Protective KIR3DL1/S1-HLA-B Genotypes Influence NK Cell-Mediated Inhibition of HIV Replication in Autologous CD4 Targets. PLoS Pathog 10(1): e32767. doi:10.1371/journal.ppat.1003867
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1003867

Souhrn

Zdroje

1. StetsonDB, MohrsM, ReinhardtRL, BaronJL, WangZE, et al. (2003) Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J Exp Med 198: 1069–1076.

2. LanierLL (2005) NK cell recognition. Annu Rev Immunol 23:225–74.: 225–274.

3. BashirovaAA, ThomasR, CarringtonM (2011) HLA/KIR restraint of HIV: surviving the fittest. Annu Rev Immunol 29: 295–317 10.1146/annurev-immunol-031210-101332 [doi].

4. PandoMJ, GardinerCM, GleimerM, McQueenKL, ParhamP (2003) The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1. J Immunol 171: 6640–6649.

5. TanerSB, PandoMJ, RobertsA, SchellekensJ, MarshSG, et al. (2011) Interactions of NK cell receptor KIR3DL1*004 with chaperones and conformation-specific antibody reveal a functional folded state as well as predominant intracellular retention. J Immunol 186: 62–72 jimmunol.0903657 [pii]; 10.4049/jimmunol.0903657 [doi].

6. YawataM, YawataN, DraghiM, LittleAM, PartheniouF, et al. (2006) Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J Exp Med 203: 633–645.

7. MartinMP, QiY, GaoX, YamadaE, MartinJN, et al. (2007) Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet 39: 733–740.

8. WanAM, EnnisP, ParhamP, HolmesN (1986) The primary structure of HLA-A32 suggests a region involved in formation of the Bw4/Bw6 epitopes. J Immunol 137: 3671–3674.

9. BouletS, KleymanM, KimJY, KamyaP, SharafiS, et al. (2008) A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection. AIDS 22: 1487–1491.

10. KamyaP, BouletS, TsoukasCM, RoutyJP, ThomasR, et al. (2011) Receptor-ligand requirements for increased NK cell poly-functional potential in *h/*y+B57 HIV-1 infected Slow progressors. J Virol JVI.02652-10 [pii]; 10.1128/JVI.02652-10 [doi].

11. KimS, SunwooJB, YangL, ChoiT, SongYJ, et al. (2008) HLA alleles determine differences in human natural killer cell responsiveness and potency. Proc Natl Acad Sci U S A 105: 3053–3058 0712229105 [pii]; 10.1073/pnas.0712229105 [doi].

12. GumperzJE, LitwinV, PhillipsJH, LanierLL, ParhamP (1995) The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med 181: 1133–1144.

13. KimS, Poursine-LaurentJ, TruscottSM, LybargerL, SongYJ, et al. (2005) Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436: 709–713 nature03847 [pii];10.1038/nature03847 [doi].

14. AnfossiN, AndreP, GuiaS, FalkCS, RoetynckS, et al. (2006) Human NK cell education by inhibitory receptors for MHC class I. Immunity 25: 331–342.

15. BouletS, SongR, KamyaP, BruneauJ, ShoukryNH, et al. (2010) HIV protective KIR3DL1 and HLA-B genotypes influence NK cell function following stimulation with HLA-devoid cells. J Immunol 184: 2057–2064 jimmunol.0902621 [pii];10.4049/jimmunol.0902621 [doi].

16. MartinMP, GaoX, LeeJH, NelsonGW, DetelsR, et al. (2002) Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 31: 429–434.

17. QiY, MartinMP, GaoX, JacobsonL, GoedertJJ, et al. (2006) KIR/HLA Pleiotropism: Protection against Both HIV and Opportunistic Infections. PLoS Pathog 2: e79.

18. AlterG, MartinMP, TeigenN, CarrWH, SuscovichTJ, et al. (2007) Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med 204: 3027–3036.

19. CocchiF, DeVicoAL, Garzino-DemoA, AryaSK, GalloRC, et al. (1995) Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270: 1811–1815.

20. OlivaA, KinterAL, VaccarezzaM, RubbertA, CatanzaroA, et al. (1998) Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. J Clin Invest 102: 223–231 10.1172/JCI2323 [doi].

21. CollinsKL, ChenBK, KalamsSA, WalkerBD, BaltimoreD (1998) HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391: 397–401.

22. CohenGB, GandhiRT, DavisDM, MandelboimO, ChenBK, et al. (1999) The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10: 661–671.

23. BrodinP, LakshmikanthT, JohanssonS, KarreK, HoglundP (2009) The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells. Blood 113: 2434–2441 blood-2008-05-156836 [pii];10.1182/blood-2008-05-156836 [doi].

24. JohanssonS, JohanssonM, RosmarakiE, VahlneG, MehrR, et al. (2005) Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules. J Exp Med 201: 1145–1155 jem.20050167 [pii];10.1084/jem.20050167 [doi].

25. FauriatC, IvarssonMA, LjunggrenHG, MalmbergKJ, MichaelssonJ (2010) Education of human natural killer cells by activating killer cell immunoglobulin-like receptors. Blood 115: 1166–1174 blood-2009-09-245746 [pii];10.1182/blood-2009-09-245746 [doi].

26. FaddaL, O'ConnorGM, KumarS, Piechocka-TrochaA, GardinerCM, et al. (2011) Common HIV-1 peptide variants mediate differential binding of KIR3DL1 to HLA-Bw4 molecules. J Virol 85: 5970–5974 JVI.00412-11 [pii];10.1128/JVI.00412-11 [doi].

27. VivianJP, DuncanRC, BerryR, O'ConnorGM, ReidHH, et al. (2011) Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B. Nature 479: 401–405 nature10517 [pii];10.1038/nature10517 [doi].

28. PelakK, NeedAC, FellayJ, ShiannaKV, FengS, et al. (2011) Copy number variation of KIR genes influences HIV-1 control. PLoS Biol 9: e1001208 10.1371/journal.pbio.1001208 [doi]; PBIOLOGY-D-11-02515 [pii].

29. BouletS, SharafiS, SimicN, BruneauJ, RoutyJP, et al. (2008) Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals. AIDS 22: 595–599.

30. BounouS, LeclercJE, TremblayMJ (2002) Presence of host ICAM-1 in laboratory and clinical strains of human immunodeficiency virus type 1 increases virus infectivity and CD4(+)-T-cell depletion in human lymphoid tissue, a major site of replication in vivo. J Virol 76: 1004–1014.